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Abstract 
Purpose: To develop a selective, sensitive and accurate simultaneous High Performance Liquid 
Chromatography (HPLC) method for the analysis of flurbiprofen and famotidine tablet dosage form and 
excipients.  
Methods: A simultaneous method for the determination of the two drugs was employed. The assay 
consisted of isocratic elution of flurbiprofen and famotidine in prepacked Column RT 250-4.6 
Purospher® STAR RP-18 end-capped (5 µm), using a mobile phase composed of acetonitrile and 
phosphate buffer (pH 3.7) in a ratio of 1:1, respectively, as well as an ultraviolet (UV) detector. 
Flurbiprofen and famotidine were both detected at 265 nm at a flow rate of 1 ml/min following the 
guidelines of International Conference of Harmonization (ICH).  
Results: A sensitive and linear range of 10 to 100 ppm with 0.999 coefficient of correlation for 
famotidine and flurbiprofen were observed. Blank and placebo showed no interference with the peak 
retention time of flurbiprofen and famotidine. Recovery of 50 mg famotidine was 99.61 % after 12 h and 
99.76 % after 7 days and for flurbiprofen 20 mg it were 99.60 % after 24 h and 99.85 % after 7 days. 
Conclusion: Good precision, recovery and accuracy data indicate the reliability of the proposed 
method. The method may also be suitable for use in bioequivalence studies. 
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Recently, there is a trend towards combined 
therapy for the treatment of various diseases and 
disorders that require long-term therapy such as 
arthritis and osteoarthritis. The main advantage 
of combined therapy is to counteract the 
destructive effects of one drug. [1]. Chemically 
Famotidine is 3-([2-(diaminomethyleneamino) 
thiazol-4-yl]methylthio)- N'-
sulfamoylpropanimidamide which is H2-receptor 
antagonist used for treating and preventing 
gastric & duodenal ulcers [2-5] and flurbiprofen is 
known as (RS)-2-(2-fluorobiphenyl-4-yl) which is  
propionic acid [6]. Structure of both drugs are 
shown in Figure 1. 
 
Bi-layer tablets are drug delivery system in which 
two drugs are combined in a single unit. 
Simultaneous method validation is used to affirm 
that analytical method for specific test is suitable 
or not. Results of method validation can be 
confirmed for their quality, reliability and 
consistency of analytical results. Various 
methods have been discussed in the literature for 
determination of Famotidine and Flurbiprofen 
tablets like spectrophotometric analysis [2], 
potentiometric [7], electrochemical, Flow injection 
analysis (FIA). Among them, High performance 
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liquid chromatography is precise, specific, rapid 
and simple. There is a need of such HPLC 
methods for detection of two drugs in a single 
dosage form. 
 
The object of this study is to formulate the bilayer 
tablets of Flurbiprofen and Famotidine by 
establishing new HPL analytical method of both 
drugs. Famotidine was used as immediate 
release (IR) and Flurbiprofen hold as sustained 
release (SR) effect. Validation of the method was 
carried out by evaluating the accuracy, precision, 





Instruments and apparatus 
 
Analytical balance   (Electronic   Balance   
Model   AED-300),   High   Performance   Liquid 
Chromatographic system (SYKAM S5111), 
Prepacked Column RT 250-4.6 Purospher ® 
STAR RP-18 end capped (5 µm), Rheodyne 
manual injector fitted with a 20 μl loop syringe 
(SGE Company, Australia), ultrasonic bath 
(Shenzhen Co. China) membrane disc filters 
(Millipore, 0.45 µm pore size, Millipore 




Famotidine and Flurbiprofen both were gifted by 
Zakfas pharmaceutical (Pvt) Ltd Multan, HPMC 
(Methocell K4M, Dow Chemical Co., USA), 
Avicel PH 102 (FMC, Brussels, Belgium), 
Carboxymethylcellulose (Ac-di-sol®, FMC 
biopolymer, USA). Potassium dihydrogen 
phosphate, methanol, phosphoric acid and 
sodium hydroxide all were purchased from 
Merck, Darmstadt, Germany and were of 
analytical grade. Double distilled water was used 
in whole study. 
 
Compression of bilayer tablets 
 
Single punch machine was used for compression 
of bilayer tablets in such a way that sustained 
release layer of Flurbiprofen granules were 
compressed initially and then immediate layer of 
Famotidine was compressed by direct 
compression. Oblong faced punch was used for 
compression of 20 mg Famotidine and 238 mg 
Flurbiprofen for obtaining the weight ranges of 
827 to 1011 mg in each tablet.  Similar 
composition of placebo (without active 
pharmaceutical ingredients) formulations were 
also compressed by same single punch machine 
for comparative study. 
 
Preparation of buffer, mobile phase and stock 
solutions 
 
Phosphate buffer solution of pH 3.7 was mixed 
with acetonitrile with the ratio 1:1. A stock 
solution of different strengths, i.e., 1 mg/ml of 
Flurbiprofen and Famotidine was prepared which 
was further diluted in 100, 50, 25 and 10 ppm 




The validation parameters determined were 
linearity, selectivity, accuracy, precision, system 
suitability, solution stability, Limit of detection 
(LOD), and Limit of quantification (LOQ) as per 




The specificity of the method was used to 
differentiate between the analyst and the 
components in the sample. Interference between 
the solvents and formulation chromatograms of 
six replicate injections of placebo with standard 
Flurbiprofen and Famotidine were evaluated for 
specificity [9]. 
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Linearity (calibration curve) 
 
To calculate the linear relationship between the 
range of concentration of the API and the 
detector response linearity curve was used. 
Linearity was assessed by forming the dilution in 
such a way that 50 ppm was kept as a central 
point, two high and two lower concentrations 
were prepared from stock solution and the 
linearity curve was developed [9]. 
 
Reproducibility and accuracy 
 
Spike Placebo method was used for calculating 
the accuracy [10]. Sample solutions with 10, 25, 
50, 75 and 10 ppm concentrations were prepared 
and spiked with placebo solution. 
 
Inter- and intra-day precision 
 
Analysis of Inter-day precision was carried out by 
selecting five concentrations for three 
consecutive days, whereas intraday precision 
was carried out by using five different 
concentrations i.e., 10, 25, 50, 75 and 100 ppm 
[11]. 
  
System suitability test (SST) 
 
The system suitability was assessed with the 
initial mobile phase composition, followed by 10 
injections of the same standard. The purpose of 
injecting 10 consecutive injections was to 
evaluate the system suitability on each day of 
method validation. Parameters like capacity 
factor > 2, resolution > 3 and asymmetric tailing 
factor < 2, theoretical plates of column > 3000 
were calculated. All parameters were recorded 





Following equations were used to evaluate the 
theoretical plates of the reports [15,16]. 
 
h=L/n ………………………………………  (1) 
 
n=16(t/Wb)2  ...………………………..........  (2) 
 
where h = theoretical plate values. Wb is the 
peak width of base, t is Retention time and L is 






where w is the width at 5 % of peak height and f 
is the distance between the maximum and 




For quantification analysis the stability of solution 
is essential. Shelf life was determined by keeping 
the sample for 12 h, and it was estimated at -15 
to -20 °C for 7 days. All the experiments were 
repeated six times. 
 
Determination of quantitation limits 
(sensitivity) 
 
Limit of detection LOD is the minute amount of 
analyte in a given method that may be detected, 
but not necessarily quantitated. To determine 
LOD of this method, 0.01 ppm of standard 
solution was injected five times and was set as 
LOD and the concentration was analyzed   by  
using the formula LOD = 3.3 SD/slope and 
subjected to regression analysis, SD and % CV 
determination.  
 
LOQ is the lowest concentration of the analyte 
that can be constituted having an acceptable 
degree of certainty [9]. Since the standard curve 
was examined from 10 to 100 ppm. Peak 
(response) was clearly identifiable, discrete and 
reproducible as requirement of Food and Drug 




Statistical analysis of the both linearity curve of 
famotidine and flurbiprofen was applied for the 
calculation of coefficient of correlation values, 
slope and y axis intercept. Microsoft Excel 2007 
was used for the evaluation of analysis of 
variance (ANOVA). Relative standard deviation 




The  method  showed  good sensitivity, 
selectivity, baseline resolved peaks and excellent 
resolution as required in method validation  
guidelines  by  the  International  Conference  on  
the  Harmonization of Pharmaceuticals for 
Human Use (ICH) Q2B [8]. Accuracy, precision, 
linearity, specificity, solution stability, system 
suitability, LOD and LOQ were successfully 
calculated. The results revealed that recovery 
was 99.611 % after 12 h and 99.760 % after 7 
days for famotidine and 99.60 % for 24 h and 
99.845 % after 7 days for flurbiprofen. 
Temperature effect on the Flurbiprofen and 
Famotidine at ambient and freeze form are 
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shown in table 1. Ambient temperature 15-20 °Ċ 
were applied for 7 days in 50 ppm solution of 
flurbiprofen and famotidine. Similarly, relative 
standard deviation (%RSD) of area for both 
drugs was 0.175 and 1.327 which is < 2. 
Theoretical plates were 4156.6 for flurbiprofen 
and 6532.2 for famotidine.  RSD of tailing factor 
was 0.986 and 0.154 % for flurbiprofen and 
famotidine, respectively, and was within limit of < 
2. LOD was 10 ppm while LOQ was 50 ppm. No 
detection of interfering recipients was detected 
between sample, standard and placebo as 
shown in Figure 2. For the evaluation of 
resolution and reproducibility of the method, the 
results of the system suitability test are shown in 
Table 2 while accuracy results are shown in table 
3. By injecting replicate injections of five selected 
concentrations 100,75,50,25 and 10 ppm gave 
the evidence of accuracy Table 3 showed the 
percent recovery for each concentration of 
Famotidine and Flurbiprofen respectively. 
Statistical data results such as coefficient of 
correlation was found to be 0.999 in Famotidine 
while it was 0.999 in Flurbiprofen which showed 
linear regression as shown in Table 2 and Figure 
3. Interdev (%RSD) precision results of 0.075, 
0.383, 0.775, 0.103, 0.155 and   0.16, 1.16, 0.15, 
0.77, 0.445 for flurbiprofen and famotidine 
respective concentration. The result of Intraday 
(%RSD) was 0.74, 1.97, 0.774,  0.66, 0.156 for 
flurbiprofen and (%RSD) for famotidine it was 
found  0.07, 1.56, 0.49, 0.06,  0.034 and analysis 
was found to be less 2 % as shown in Table 4. 
 
 



















































Figure 2:  Specificity of the method at 1 ml/min flow rate of mobile phase, placebo and standard having total run 
time of 20 min 
 
 
Figure  3: Linearity chromatograms of different concentration of flurbiprofen and famotidine 
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Table 2: System suitability and statistical parameters of flurbiprofen and famotidine 
 
Drug  Consideration Mean (n = 10) RSD (%) 
Flurbiprofen Retention Time 2.457 min 0.006 
Area 3131.87 0.174 
Tailing Factor 321.548 0.986 
Theoretical Plates 4156.6 1.02 
Coefficient of correlation 0.999 - 
Linearity equation 53.578x-345.84 
Famotidine Retention Time 4.163min 0.443 
Area 2538 1.327 
Tailing Factor 543.21 0.154 
Theoretical Plates 6532.2 1.63 
Coefficient of correlation 0.999 - 
Linearity equation          40.977x-406.76 
 






mean ± SD (n = 2) 
Recovery (%) 
(n = 2) 
Found (µg/ml) 
mean ± SD (n = 2) 
Recovery (%) 
(n = 2) 
10 9.921 ± 0.02 99.194 10.035 ± 1.210 100.351 
25 25.605 ± 0.012 102.421 24.781 ± 1.021 99.121 
50 49.261 ± 0.012 98.522 49.731 ± 1.301 99.471 
75 75.095 ± 0.110 74.095 76.061 ± 0.811 101.411 
100 100.612 ± 0.160 100.610 99.381 ± 0.721 99.380 
 
Table 4: Precision of the proposed method (Mean ± SD, n = 3) 
 
  Drug Precision Concentrations (ug/ml) 






 RSD (%) 
9.45 ± 0.01 25.06 ±  0.10 48.39 ±0.37 74.93 ±0.08 99.76 ±0.16 
0.075 0.383 0.775 0.103 0.155 
 Intra Day 
 RSD (%) 
9.445 ±0.01 24.78 ±0.49 48.385 ±0.37 76.06 ±0.50 99.76 ±0.16 





 RSD (%) 
9.79 ± 0.17 25.88 ± 0.29 49.4 ± 0.74 75.56 ±0.59 100.19 ±0.45 
0.16 1.16 0.150 0.77 0.445 
 Intra Day 
 RSD (%) 
9.865 ±0.01 25.26 ±0.40 49.15 ±0.24 75.15 ±0.05 99.845 ±0.04 




The retention time for placebo and blank 
chromatograms were 16.823 and 6.613 min 
respectively. Similar studies were also performed 
by Hanif et al to evaluate the Nimesulide 
concentration in tablet dosage form [9]. Lesser in 
retention time will provide the benefit of less 
consumption of mobile phase and less time 
needed for the assay of both drugs. Retention 
time for system suitability was 2.457 min for 
flurbiprofen and 4.163 min for famotidine. 
Similarly percentage relative standard deviation 
(%RSD) of area for both drugs was 0.175 and 
1.327 which is less than 2. Theoretical plates 
were found 4156.6 for flurbiprofen and 6532.2 for 
famotidine.  A % RSD value of tailing factor was 
0.986 and 0.154 for flurbiprofen and famotidine 
respectively and was found within limit less than 
2. Similarly stability of amlodipine besylate and 
atenolol in multi-component tablets of mono-layer 
and bi-layer types were studied by Aryal et al in 
2008 and developed a single mobile phase to 
specify of the reported method [13]. 
 
For determination of linearity, five concentrations 
(ICH, 1996) having an equal spaced i.e. 100, 75, 
50, 25, 10 ppm were applied and their recovery 
were found to be 9.92, 25.605, 49.56, 75.095, 
100.6 ppm respectively for famotidine and 
10.035, 24.78, 49.73, 76.06, 99.38 ppm for 
flurbiprofen. In similar study Linearity values of 
pseudoephedrine and cetirizine was also 
developed after compressing the bilayer tablet 
and developing single mobile phase for both 
drugs [14] 
 
System suitability parameters include Relative 
Standard Deviation (RSD), Percentage of 
Retention Time, Peak area, Tailing Factor and 
Theoretical plates were observed as expressed 
in Table 2. All results were within limits of ICH 
guideline. Shah et al reported same results after 
studying the combined formulation [15]. Similarly 
succinate and amlodipine was studied in bilayerd 
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tablets formulations and reported the system 
suitability with its theoretical plates values [16]. 
 
By injecting replicate injections of five selected 
concentrations 100,75,50,25 and 10 ppm gave 
the evidence of accuracy Table 3 showed the 
percent recovery for each concentration of 
Famotidine and Flurbiprofen respectively. Similar 
findings were reported for determination of 
Flurbiprofen by HPLC and reported the accuracy 
level of five different concentrations [17]. 
Ampicillin and cloxacillin were in the combined 
formulation was studied and reported accurate 
and precise method for both drugs [18]. 
 
For the determination of precision intraday and 
inter-day analyses were carried out by injecting 
twice the five concentrations of 100, 75, 50, 25, 
10 ppm of both Famotidine and Flurbiprofen 
were applied on the same day and for three 
consecutive days. Interday (%RSD) precision 
results of 0.075, 0.383, 0.775, 0.103, 0.155 and   
0.16, 1.16, 0.15, 0.77, 0.445 for flurbiprofen and 
famotidine respective concentration. The result of 
intraday (%RSD) was 0.74, 1.97, 0.774,  0.66, 
0.156 for flurbiprofen and (%RSD) for famotidine 
it was found  0.07, 1.56, 0.49, 0.06,  0.034 and 
analysis was found to be less 2 % as shown in 
Table 4. Similar finding were also reported by 
after explaining the HPLC method validation of 
Nimesulide tablets [9]. Atorvastatin and 
amlodipine were studied in combined formulation 
and reported the isocratic mobile phase of both 




The HPLC method used shows good separation, 
linearity, precision, accuracy and selectivity for 
the simultaneous analysis of the two drugs, and it 
should also be convenient, simple and reliable to 
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